GROWTH OPPORTUNITIES IN  GENE THERAPIES, CANCER, DISEASE TREATMENT & MONITORING, SURGICAL APPLICATIONS AND COSMETICS

GROWTH OPPORTUNITIES IN  GENE THERAPIES, CANCER, DISEASE TREATMENT & MONITORING, SURGICAL APPLICATIONS AND COSMETICS

RELEASE DATE
22-Jan-2021
REGION
Global
Research Code: D759-00-1C-00-00
SKU: HC03386-GL-TA_25198
$950.00
In stock
SKU
HC03386-GL-TA_25198
$950.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) consists of insights across gene therapies, cancer, neurological, allergic and respiratory diseases treatment and monitoring. Further, novel drugs, drug delivery systems, surgical support applications, artificial intelligence-based imaging, as well as telehealth systems are discussed. Some innovations cover the upcoming innovations in cosmetics, acne treatment, food packing, and natural extract processing technologies

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Pancreatic cancer, bone marrow transplantation, non-Hodgkin’s lymphoma, gene therapy, fetal therapy, lipid nanoparticles, prenatal genetic therapy, non-viral vector gene therapy, Uveal melanoma, age-related macular degeneration, Stargardt disease, Angioedema, hematopoietic cell therapy, acute myeloid leukemia, HIV, long-acting injectable drugs, bone graft substitute, osteomyelitis, orphan disease, immune thrombocytopenia, rhinitis, COVID-19, acne treatment, colonoscopy, Alzheimer disease, telehealth, AI-based medical imaging, blood oxygen monitoring, radio frequency-based treatment, neurointerventional surgeries, nanoliposome, drug-encapsulation, radionucleotide, glioblastoma, Molluscum contagiosum, tissue sealant, mussel polymer, food and beverage packaging, renewable adhesives, natural extract processing, cosmetics, sulfate-free foaming agent

Table of Contents

INNOVATIONS IN LIFE SCIENCES, HEALTH & WELLNESS

  • RENOVORX, US
  • HOTH THERAPEUTICS, US
  • SWEDISH ORPHAN BIOVITRUM AB, SWEDEN
  • TYTO CARE, US
  • SCOPUS BIOPHARMA INC., US
  • BIOLINERX, ISRAEL
  • INNODEM NEUROSCIENCES, CANADA
  • CHILDREN’S HOSPITAL OF PHILADELPHIA & UNIVERSITY OF PENNSYLVANIA, US
  • NEURENT MEDICAL, IRELAND
  • IMMUNOCORE, UK
  • MIVI NEUROSCIENCE, US
  • BIOCLINICA, US
  • BELITE BIO INC., CA, US
  • PLUS THERAPEUTICS INC., US
  • BIOCRYST PHARMACEUTICALS INC., US
  • VERRICA PHARMACEUTICALS INC., US
  • LYGENESIS, US
  • SEBELA PHARMACEUTICALS, US
  • HELIX, US
  • VOR BIOPHARMA, UK
  • SUSTAINABLE ADHESIVE PRODUCTS™ LTD., NETHERLANDS
  • MUSSEL POLYMERS INC., US
  • BIO-BOTANICA INC., US
  • LACHEMI CHEMORGS, INDIA
  • LOCATE BIO LIMITED, UK
  • VIIV HEALTHCARE, US

KEY CONTACTS

  • KEY CONTACTS
  • KEY CONTACTS
  • KEY CONTACTS
  • KEY CONTACTS
  • KEY CONTACTS
  • KEY CONTACTS
  • KEY CONTACTS
  • LEGAL DISCLAIMER
Related Research
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) consists of insights across gene therapies, cancer, neurological, allergic and respiratory diseases treatment and monitoring. Further, novel drugs, drug delivery systems, surgical support applications, artificial intelligence-based imaging, as well as telehealth systems are discussed. Some innovations cover the upcoming innovations in cosmetics, acne treatment, food packing, and natural extract processing technologies The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Pancreatic cancer, bone marrow transplantation, non-Hodgkins lymphoma, gene therapy, fetal therapy, lipid nanoparticles, prenatal genetic therapy, non-viral vector gene therapy, Uveal melanoma, age-related macular degeneration, Stargardt disease, Angioedema, hematopoietic cell therapy, acute myeloid leukemia, HIV, long-acting injectable drugs, bone graft substitute, osteomyelitis, orphan disease, immune thrombocytopenia, rhinitis, COVID-19, acne treatment, colonoscopy, Alzheimer disease, telehealth, AI-based medical imaging, blood oxygen monitoring, radio frequency-based treatment, neurointerventional surgeries, nanoliposome, drug-encapsulation, radionucleotide, glioblastoma, Molluscum contagiosum, tissue sealant, mussel polymer, food and beverage packaging, renewable adhesives, natural extract processing, cosmetics, sulfate-free foaming agent
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number D759-00-1C-00-00
Is Prebook No
Ti Codes D759